Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on April 23, 2025

Codex Labs Bia Ultra-Hydrating Soothing Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome
San Jose, CA, USA, April 23, 2025 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley skintech company, announced that its Bia Ultra-Hydrating Soothing Lotion, the European version of its US Bia over-the-counter (OTC) Bia Eczema Relief Lotion has been awarded …

TASSHUB Debuts Market for Creators on Solana, it's 484% up in just 24 Hours After Launch
HARNDUP, Denmark, April 23, 2025 (GLOBE NEWSWIRE) -- Creator-based Web 3 platform TASSHUB token officially launched on Solana Thursday, with the promise of bridging decentralization to the adult entertainment industry. Now visible on market aggregator …

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
Five abstracts accepted for poster presentations WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today …

TomTom provides enhanced navigation to smart’s in-vehicle solutions
SHANGHAI, April 23, 2025 (GLOBE NEWSWIRE) -- Auto Shanghai – TomTom (TOM2), the location technology specialist, today announced that it has been selected by smart, the premium all-electric intelligent auto brand, to provide enhanced full-stack navigation …

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
VERAXA’s Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug Conjugate ("ADC") and Bispecific T-cell Engager ("TCE") Candidates, with Strong and Differentiated Clinical …

20th China Huabiao Film Awards Ceremony to Be Held in Qingdao on April 27
QINGDAO, China, April 23, 2025 (GLOBE NEWSWIRE) -- To mark the 120th anniversary of Chinese cinema, the event titled "Building Dreams through Film, Embracing the Spirit of the Era -- The 20th China Huabiao Film Awards Ceremony" will take place in Qingdao, …

Update on Transaction Regulatory Approvals
BRISBANE, Australia, April 23, 2025 (GLOBE NEWSWIRE) -- Sayona Mining Limited (“Sayona” or “Company”) (ASX:SYA; OTCQB:SYAXF) provides an update on the proposed transaction with Piedmont Lithium Inc. (“Piedmont Lithium”) (NASDAQ:PLL, ASX:PLL) (see …

Notes-App.AI Launches Smarter Notes AI Platform for Everyday Creativity
New York, April 23, 2025 (GLOBE NEWSWIRE) -- Today, Notes-App.AI officially launched its groundbreaking Notes AI platform, transforming the process of how humans take, manage, and interact with their individual ideas. A next-generation notes app, Notes-App …

Verizon’s 2025 Data Breach Investigations Report: System Intrusions Behind 80% of APAC Breaches
SINGAPORE, April 23, 2025 (GLOBE NEWSWIRE) -- Verizon Business today released its 2025 Data Breach Investigations Report (DBIR), sounding the alarm on a surge of system intrusions across the Asia-Pacific region. The report reveals that 4 out of 5 data …

Verizon’s 2025 Data Breach Investigations Report: System Intrusion Breaches Double in EMEA
LONDON, April 23, 2025 (GLOBE NEWSWIRE) -- Verizon Business today released its 2025 Data Breach Investigations Report (DBIR), revealing a dramatic surge in global data breaches, with EMEA experiencing a significant increase in system intrusion breaches. …

CMVC adquiere Orlando Medical Institute y expande su portafolio educativo en el campo de salud con programas de paramédico y atención médica de emergencia
ORLANDO, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Compu-Med Vocational Careers (CMVC), anuncia la adquisición de Orlando Medical Institute (OMI). Esta adquisición estratégica acelera la expansión de los programas educativos en salud de CMVC al agregar …

浩鼎将在AACR发表七篇海报论文
台北讯, April 23, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技(TPEx: 4174.TWO)今日首次公布其自主开发的次世代GlycOBI®技术平台所开发抗体药物偶联体(ADC)OBI-902的非临床数据,显示其具备优异的药物动力学特性,并在多种具挑战性的实体肿瘤动物模型中展现持续的抗肿瘤活性,且优于目前已上市的TROP2 ADC,显示OBI-902具备成为同类最佳ADC的潜力。OBI-992则为采用半胱氨酸连接技术的TROP2靶向ADC,其耐药性特征异于现有同类产品。 在本次 …

浩鼎將在AACR發表七篇海報論文
台北電, April 23, 2025 (GLOBE NEWSWIRE) -- 台灣浩鼎生技(TPEx: 4174. TWO)今首度公布其自主開發的次世代 GlycOBI® 技術平台所開發抗體藥物複合體(ADC)OBI-902 非臨床數據,具有優異的藥物動力學特性,以及在多種具挑戰性的實體腫瘤動物模型中展現持續的抗腫瘤活性,亦證明優於目前已上市的 TROP2 ADC,證明OBI-902 具有成為同類最佳ADC的潛力。OBI-992 為半胱胺酸連接技術的 TROP2 靶向 ADC,其耐藥性特徵有異於目前同類的 …

OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI® and ThiOBI® ADC enabling technologies, the OBI-3424 prodrug, and Globo H (GH) science
TAIPEI, Taiwan, April 23, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO) today announced nonclinical data for OBI-902, a potential best-in-class anti-TROP2 ADC developed using the next generation proprietary GlycOBI® technologies. OBI-902 …

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025
Salt Lake City, UT, April 22, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data during the 2025 Digestive Disease Week (DDW) meeting from …

FLNC DEADLINE ALERT: Kirby McInerney LLP Alerts Fluence Energy, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP alerts investors of the imminent May 12, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Fluence …

SWKS DEADLINE ALERT: Kirby McInerney LLP Alerts Skyworks Solutions, Inc. Investors of Important Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP alerts investors of the imminent May 5, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired …